Showing 1 - 9 results of 9 for search 'Kate Hayes', query time: 0.04s
Refine Results
-
1
-
2
Sweat Chloride Testing and Nasal Potential Difference (NPD) Are Primary Outcome Parameters in Treatment with Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators by Isabelle Sermet-Gaudelus, Thao Nguyen-Khoa, Aurélie Hatton, Kate Hayes, Iwona Pranke
Published 2021-07-01
Article -
3
-
4
-
5
-
6
Isolation, cultivation, and application of primary respiratory epithelial cells obtained by nasal brushing, polyp samples, or lung explants by Anita Golec, Iwona Pranke, Paolo Scudieri, Kate Hayes, Elise Dreano, Fiona Dunlevy, Aurelie Hatton, Damian G. Downey, Luis Galietta, Isabelle Sermet
Published 2022-06-01
Article -
7
Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures by Silke van Koningsbruggen-Rietschel, Fiona Dunlevy, Veerle Bulteel, Kate Hayes, Anne Verbrugge, Hettie M. Janssens, Nadine Dufeu, Nicholas J. Simmonds, Lieven J. Dupont, Damian G. Downey
Published 2021-08-01
Article -
8
Agents of change: establishing quality improvement collaboratives to improve adherence to Australian clinical guidelines for dementia care by Monica Cations, Maria Crotty, Janna Anneke Fitzgerald, Susan Kurrle, Ian D. Cameron, Craig Whitehead, Jane Thompson, Billingsley Kaambwa, Kate Hayes, Lenore de la Perrelle, Gorjana Radisic, Kate E. Laver
Published 2018-09-01
Article -
9
Improving adherence to guideline recommendations in dementia care through establishing a quality improvement collaborative of agents of change: an interrupted time series study by Kate Laver, Monica Cations, Gorjana Radisic, Lenore de la Perrelle, Richard Woodman, Janna Anneke Fitzgerald, Susan Kurrle, Ian D. Cameron, Craig Whitehead, Jane Thompson, Billingsley Kaambwa, Kate Hayes, Maria Crotty
Published 2020-09-01
Article